Roles of CXCL8 in squamous cell carcinoma proliferation and migration

Oral Oncology

Volumn 44, Issue 10, 2008, Pages 920-926

  Christofakis, Emil P ^a   Miyazaki, Hiroshi ^a   Rubink, Dustin S ^a   Yeudall, W Andrew ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

Growth factor; Invasion; Squamous cell carcinoma

Indexed keywords

CHEMOKINE; INTERLEUKIN 8; RNA;

ARTICLE; BASEMENT MEMBRANE; CELL COUNT; CELL GROWTH; CELL INVASION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; METASTASIS; PRIMARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA INTERFERENCE; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA; TUMOR CELL; TUMOR GROWTH;

BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-8; MALE; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TONGUE NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 51649105726     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.12.002     Document Type: Article

References (46)

1. McMahon S., and Chen A.Y. Head and neck cancer. Cancer Metastasis Rev 22 1 (2003) 21-24
2. Kim M.M., and Califano J.A. Molecular pathology of head-and-neck cancer. Int J Cancer 112 4 (2004) 545-553
3. Aggarwal B.B., Shishodia S., Sandur S.K., Pandey M.K., and Sethi G. Inflammation and cancer: how hot is the link?. Biochem Pharmacol 72 11 (2006) 1605-1621
4. Lawrence T. Inflammation and cancer: a failure of resolution?. Trends Pharmacol Sci 28 4 (2007) 162-165
5. Aggarwal B.B. Nuclear factor-kappaB: the enemy within. Cancer Cell 6 3 (2004) 203-208
6. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 6917 (2002) 860-867
7. Mantovani A. Cancer: inflammation by remote control. Nature 435 7043 (2005) 752-753
8. Laing K.J., and Secombes C.J. Chemokines. Dev Comp Immunol 28 5 (2004) 443-460
9. Balkwill F. Cancer and the chemokine network. Nat Rev Cancer 4 7 (2004) 540-550
10. Schraufstatter I.U., Chung J., and Burger M. IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280 6 (2001) L1094-L1103
11. Strieter R.M., Burdick M.D., Mestas J., Gomperts B., Keane M.P., and Belperio J.A. Cancer CXC chemokine networks and tumour angiogenesis. Eur J Cancer 42 6 (2006) 768-778
12. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12 4 (2001) 375-391
13. Brasier A.R., Jamaluddin M., Casola A., Duan W., Shen Q., and Garofalo R.P. A promoter recruitment mechanism for tumor necrosis factor-alpha-induced interleukin-8 transcription in type II pulmonary epithelial cells. Dependence on nuclear abundance of Rel A, NF-kappaB1, and c-Rel transcription factors. J Biol Chem 273 6 (1998) 3551-3561
14. Villarete L.H., and Remick D.G. Nitric oxide regulation of interleukin-8 gene expression. Shock 7 1 (1997) 29-35
15. Shi Q., Abbruzzese J.L., Huang S., Fidler I.J., Xiong Q., and Xie K. Constitutive and inducible interleukin 8 expression by hypoxia and acidosis renders human pancreatic cancer cells more tumorigenic and metastatic. Clin Cancer Res 5 11 (1999) 3711-3721
16. Miyazaki H., Patel V., Wang H., Ensley J.F., Gutkind J.S., and Yeudall W.A. Growth factor-sensitive molecular targets identified in primary and metastatic head and neck squamous cell carcinoma using microarray analysis. Oral Oncol 42 3 (2006) 240-256
17. Miyazaki H., Patel V., Wang H., Edmunds R.K., Gutkind J.S., and Yeudall W.A. Downregulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res 66 8 (2006) 4279-4284
18. Edmiston J.S., Yeudall W.A., Chung T.D., and Lebman D.A. Inability of transforming growth factor-beta to cause SnoN degradation leads to resistance to transforming growth factor-beta-induced growth arrest in esophageal cancer cells. Cancer Res 65 11 (2005) 4782-4788
19. Yeudall W.A., Crawford R.Y., Ensley J.F., and Robbins K.C. MTS1/CDK4I is altered in cell lines derived from primary and metastatic oral squamous cell carcinoma. Carcinogenesis 15 12 (1994) 2683-2686
20. Cardinali M., Pietraszkiewicz H., Ensley J.F., and Robbins K.C. Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies. Int J Cancer 61 1 (1995) 98-103
21. Jakus J., and Yeudall W.A. Growth inhibitory concentrations of EGF induce p21 (WAF1/Cip1] and alter cell cycle control in squamous carcinoma cells. Oncogene 12 11 (1996) 2369-2376
22. Yeudall W.A., Miyazaki H., Ensley J.F., Cardinali M., Gutkind J.S., and Patel V. Uncoupling of epidermal growth factor-dependent proliferation and invasion in a model of squamous carcinoma progression. Oral Oncol 41 (2005) 698-708
23. Yeudall W.A., and Miyazaki H. Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention?. Expert Rev Anticancer Ther 7 3 (2007) 351-360
24. Metzner B., Hofmann C., Heinemann C., Zimpfer U., Schraufstatter I., Schopf E., et al. Overexpression of CXC-chemokines and CXC-chemokine receptor type II constitute an autocrine growth mechanism in the epidermoid carcinoma cells KB and A431. Oncol Rep 6 6 (1999) 1405-1410
25. Bailey C., Negus R., Morris A., Ziprin P., Goldin R., Allavena P., et al. Chemokine expression is associated with the accumulation of tumour associated macrophages (TAMs) and progression in human colorectal cancer. Clin Exp Metastasis 24 2 (2007) 121-130
26. Varney M.L., Johansson S.L., and Singh R.K. Distinct expression of CXCL8 and its receptors CXCR1 and CXCR2 and their association with vessel density and aggressiveness in malignant melanoma. Am J Clin Pathol 125 2 (2006) 209-216
27. Brat D.J., Bellail A.C., and Van Meir E.G. The role of interleukin-8 and its receptors in gliomagenesis and tumoral angiogenesis. Neuro-oncology 7 2 (2005) 122-133
28. Son D.S., Parl A.K., Rice V.M., and Khabele D. Keratinocyte chemoattractant (kc)/human growth-regulated oncogene (gro) chemokines and pro-inflammatory chemokine networks in mouse and human ovarian epithelial cancer cells. Cancer Biol Ther 6 8 (2007)
29. Kunsch C., and Rosen C.A. NF-kappa B subunit-specific regulation of the interleukin-8 promoter. Mol Cell Biol 13 10 (1993) 6137-6146
30. Karin M., and Greten F.R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5 10 (2005) 749-759
31. Keane M.P., and Strieter R.M. Chemokine signaling in inflammation. Crit Care Med 28 Suppl. 4 (2000) N13-N26
32. Richmond A., Fan G.H., Dhawan P., and Yang J. How do chemokine/chemokine receptor activations affect tumorigenesis?. Novartis Found Symp 256 (2004) 74-89 [discussion 89-91, 106-11, 266-9]
33. Venkatakrishnan G., Salgia R., and Groopman J.E. Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275 10 (2000) 6868-6875
34. Li A., Dubey S., Varney M.L., Dave B.J., and Singh R.K. IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis. J Immunol 170 6 (2003) 3369-3376
35. Li A., Varney M.L., Valasek J., Godfrey M., Dave B.J., and Singh R.K. Autocrine role of interleukin-8 in induction of endothelial cell proliferation, survival, migration and MMP-2 production and angiogenesis. Angiogenesis 8 1 (2005) 63-71
36. Handsley M.M., and Edwards D.R. Metalloproteinases and their inhibitors in tumor angiogenesis. Int J Cancer 115 6 (2005) 849-860
37. Itoh Y., Joh T., Tanida S., Sasaki M., Kataoka H., Itoh K., et al. IL-8 promotes cell proliferation and migration through metalloproteinase-cleavage proHB-EGF in human colon carcinoma cells. Cytokine 29 6 (2005) 275-282
38. Luppi F., Longo A.M., de Boer W.I., Rabe K.F., and Hiemstra P.S. Interleukin-8 stimulates cell proliferation in non-small cell lung cancer through epidermal growth factor receptor transactivation. Lung Cancer 56 1 (2007) 25-33
39. Ozanne B., Richards C.S., Hendler F., Burns D., and Gusterson B. Over-expression of the EGF receptor is a hallmark of squamous cell carcinomas. J Pathol 149 1 (1986) 9-14
40. Partridge M., Green M.R., Langdon J.D., and Feldmann M. Production of TGF-alpha and TGF-beta by cultured keratinocytes, skin and oral squamous cell carcinomas-potential autocrine regulation of normal and malignant epithelial cell proliferation. Br J Cancer 60 4 (1989) 542-548
41. Prime S.S., Game S.M., Matthews J.B., Stone A., Donnelly M.J., Yeudall W.A., et al. Epidermal growth factor and transforming growth factor alpha characteristics of human oral carcinoma cell lines. Br J Cancer 69 1 (1994) 8-15
42. Strieter R.M., Belperio J.A., Phillips R.J., and Keane M.P. CXC chemokines in angiogenesis of cancer. Semin Cancer Biol 14 3 (2004) 195-200
43. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 258 5089 (1992) 1798-1801
44. Heidemann J., Ogawa H., Dwinell M.B., Rafiee P., Maaser C., Gockel H.R., et al. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2. J Biol Chem 278 10 (2003) 8508-8515
45. Keane M.P., Belperio J.A., Xue Y.Y., Burdick M.D., and Strieter R.M. Depletion of CXCR2 inhibits tumor growth and angiogenesis in a murine model of lung cancer. J Immunol 172 5 (2004) 2853-2860
46. Wente M.N., Keane M.P., Burdick M.D., Friess H., Buchler M.W., Ceyhan G.O., et al. Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis. Cancer Lett 241 2 (2006) 221-227